FiscalNote Acquires EU Regulatory Intelligence Leader Shungham
FiscalNote, the Washington, D.C.-based company that dramatically improves the way organizations engage with government, today announced at the World Economic Forum in Switzerland, its acquisition of Brussels-based Shungham, a provider of systematic regulatory and legislative intelligence about European Union issues through its flagship product “EU Issue Tracker”. The move expands FiscalNote’s international leadership in the government relationship management (GRM) sector where it already provides data on regulatory and legislative issues for EU Member States and more than 20 countries worldwide. As one of the largest companies in the global market, the combined organization will provide the most comprehensive legislative and regulatory data and workflows for the EU and its Member States.
Founded in 2010 with a strong reputation for the highly-structured analysis and subject matter expertise EU regulatory issues require, Shungham’s EU Issue Tracker helps major global brands including Coca-Cola, L’Oreal, Nestle, Siemens, and BMW better understand potential regulation as it is being developed. With the most comprehensive data and analysis in a market where automated intelligence is difficult due to differing reporting requirements by country, Shungham provides a critical edge to its clients in strategic regulatory intelligence and compliance.
“As the changes in the global political landscape are giving rise to new and evolving needs in political advocacy, our clients have been asking for more actionable intelligence about the EU and its member states, along with other strategic global regions,” said Tim Hwang, co-founder and CEO of FiscalNote and a WEF Technology Pioneer. “Shungham adds a much needed human element to our AI-powered intelligence that will give our clients more insight into legislative and regulatory issues at all stages of development. As we focus at the World Economic Forum about making connections in an evolving world, this deal will empower organizations worldwide to be more effective in their engagements with government and stay aware of global updates.”
FiscalNote created the GRM category nearly two years ago with the first comprehensive engagement platform, services, and mobile application. The platform now includes data from 20 countries, and expects to rapidly expand across the world in 2018 in the hopes of one day reaching every country in the world. Shungham is the second acquisition announced in the last six months as FiscalNote attempts to grow its global presence and capabilities for its customers.
“As Brexit nears, there is a rapidly growing need for strategic intelligence on both the EU and its Members States among our clients, and joining FiscalNote gives us the ability to rapidly scale our human-curation approach and apply automation for the first time,” said Michel Ehrlich, CEO of Shungham. “The combination of our depth of intelligence in this market along with FiscalNote’s collaboration and issues management tools will allow our clients to more easily take strategic action on issues that affect their business.”
FiscalNote is a leading technology innovator at the intersection of global business & government. With offices in DC, NYC, Baton Rouge, Seoul, India, and Brussels, the company has raised more than $43 million from prominent early-stage investors including Renren, First Round Capital’s Dorm Room Fund, Green Visor Capital, MoneyToday, Visionnaire Ventures, Perle Ventures, 645 Ventures, Steve Case, Mark Cuban and Jerry Yang/AME Cloud Ventures. FiscalNote has grown to become one of the largest privately held companies in the legal analytics space, powering 21.9 million users and 1,300 law firms, legal departments and governments across its platforms. FiscalNote is revolutionizing access to legislation, regulations and court cases for organizations around the world. Organizations — from small startups and non-profits to multinational corporations — that rely on FiscalNote’s revolutionary government relationship management (GRM) and grassroots advocacy solutions include Cargill, Toyota, Intel, Johnson & Johnson, the Pharmaceutical Care Management Association, Microsoft, PhRMA, Salesforce, the Consumer Technology Association, Anthem BlueCross BlueShield, Schlumberger, Macy’s, and the National Education Association.
FiscalNote is a World Economic Forum Technology Pioneer.
Julie Walsh, Finn Partners
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00 | Pressemelding
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26 | Pressemelding
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05 | Pressemelding
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03 | Pressemelding
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and